190 related articles for article (PubMed ID: 37565164)
21. Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2023; 2023():9841321. PubMed ID: 38075334
[TBL] [Abstract][Full Text] [Related]
22. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
[TBL] [Abstract][Full Text] [Related]
23. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract][Full Text] [Related]
24. Budd Chiari Syndrome and Intrahepatic Cholangiocarcinoma, An Unusual Combination: Case Report and Review of the Literature.
Elhence A; Gamanagatti S; Das P;
Perm J; 2020 Nov; 24():1-3. PubMed ID: 33482951
[TBL] [Abstract][Full Text] [Related]
25. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
26. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
[TBL] [Abstract][Full Text] [Related]
27. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports.
Jung KS; Chun KH; Choi GH; Jeon HM; Shin HS; Park YN; Park JY
BMC Res Notes; 2013 Dec; 6():520. PubMed ID: 24313990
[TBL] [Abstract][Full Text] [Related]
28. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
[TBL] [Abstract][Full Text] [Related]
30. Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Connell LC; Harding JJ; Shia J; Abou-Alfa GK
Chin Clin Oncol; 2016 Oct; 5(5):66. PubMed ID: 27829279
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between hepatic alveolar echinococcosis and primary hepatic malignancy with diffusion-weighted magnetic resonance imaging.
Sade R; Kantarci M; Ogul H; Gundogdu B; Aydınlı B
Diagn Interv Imaging; 2018 Mar; 99(3):169-177. PubMed ID: 29110943
[TBL] [Abstract][Full Text] [Related]
32. Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies.
Bai H; Gayyed MF; Lam-Himlin DM; Klein AP; Nayar SK; Xu Y; Khan M; Argani P; Pan D; Anders RA
Hum Pathol; 2012 Sep; 43(9):1376-85. PubMed ID: 22436626
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
34. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
[TBL] [Abstract][Full Text] [Related]
35. Retraction Note: LINC01296 promotes the proliferation and invasion by regulating microRNA-760 expression and predicts poor prognosis of hepatocellular carcinoma.
Wang ZC; Yang S; Chen MQ; Wu SS; Lv HH; Jin WX
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):442. PubMed ID: 36734696
[TBL] [Abstract][Full Text] [Related]
36. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
[TBL] [Abstract][Full Text] [Related]
37. Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma-Own Experiences and Review of the Literature.
Schwenk L; Rohland O; Ali-Deeb A; Dondorf F; Settmacher U; Rauchfuß F
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509271
[TBL] [Abstract][Full Text] [Related]
38. The prognostic relationship between histopathological and immunohistochemical features of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and mixed type.
Çabuk F; Başsüllü N; Türkmen İ; Dayangaç M; Akyıldız M; Yüzer Y; Tokat Y; Doğusoy G
Pol J Pathol; 2020; 71(2):79-86. PubMed ID: 32729298
[TBL] [Abstract][Full Text] [Related]
39. Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma.
Wen KW; Joseph NM; Srivastava A; Saunders TA; Jain D; Rank J; Feely M; Zarrinpar A; Al Diffalha S; Shyn PB; Graham RP; Drage MG; Kakar S
Hum Pathol; 2021 Oct; 116():82-93. PubMed ID: 34298064
[TBL] [Abstract][Full Text] [Related]
40. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
